Register for free to listen to this article
Listen with Speechify
0:00
2:00
PRINCETON, N.J.—Certara, a global biosimulation technology-enabled drug development company, recently launched an e-learning platform through Certara University to satisfy the increased need for education in the burgeoning field of biosimulation, or model-based drug development. With the addition of this new on-demand content, scientists from all over the world, with differing skill levels in biosimulation, will be able to access the educational assets developed by Certara’s scientific leaders, the company says.
 
“The use of biosimulation in drug development has evolved from being a research nicety to a regulatory necessity,” said Certara CEO Dr. Edmundo Muniz. “In fact, the U.S. Food and Drug Administration and European Medicines Agency have recommended biosimulation in more than a dozen draft regulatory guidance documents and its use is now expected by regulators. As sponsor companies increase their use of biosimulation to inform pivotal drug development decisions and interact with regulators, ongoing education is becoming of paramount importance to ensure they optimize their application of this technology.”
 
“Biosimulation’s rapid adoption has created a growing global demand for education in pharmacometrics theory and technologies,” added Nathan Teuscher, Certara’s vice president of scientific training. “We are proud to be expanding Certara University’s reach by providing e-learning classes so we can continue to share our knowledge and experience with drug development researchers around the world in the most effective formats available.”
 
In addition to the recognized advantages of being able to take a class at the most convenient time with no travel involved, the biosimulation e-learning courses also allow participants to gain access to world-class trainers and learn at their own pace, Certara says, citing data from Applied Cognitive Psychology magazine indicating that deeper learning occurs when participants can control the rate at which they move through segmented content. In addition, Certara notes, the Research Institute of America reports that e-learning increases information retention rates by up to 60 percent.

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue